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We characterized the full-length genomes for nine novel variants of HCV genotype 4 (HCV-4),
representing a new subtype 4s and eight unclassiﬁed lineages. They were obtained from patients who
resided in Canada but all had origins in Africa. An extended maximum clade credibility (MCC) tree was
reconstructed after the inclusion of 30 reference sequences. It differentiated 18 assigned subtypes and 10
unclassiﬁed lineages within HCV-4. Similar analysis of 102 partial NS5B sequences resulted in another
MCC tree that revealed 22 assigned subtypes (4a–4t, 4w, and 4v) and 30 unclassiﬁed lineages at the
subtype level. Our study shows that HCV-4 is taxonomically complex and it displays high genetic
diversity to support an African origin.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Hepatitis C virus (HCV) is a blood-borne pathogen that infects an
estimated 115million people worldwide or approximately 1.3–2.1% of
the global population (Gower et al., 2014). HCV infection is char-
acterized by the establishment of chronic hepatitis in about 70–85%
of the infected individuals among whom many develop hepatocel-
lular carcinoma, liver cirrhosis, and liver failure (Hoofnagle, 2002;
Zoulim et al., 2003). Eventually, these end-stage liver diseases cause
substantial morbidity and mortality (Razavi et al., 2014).
HCV possesses a single stranded, positive-sense RNA genome
of about 9600 nucleotides in length. HCV is classiﬁed into the
Hepacivirus genus of the Flaviviridae family and has a high degree
of genetic diversity (Thiel et al., 2005). Accordingly, HCV can be
divided into seven genotypes and each genotype, excluding
genotypes 5 and 7, is further divided into a number of subtypes.
Currently, 82 subtypes of HCV have been conﬁrmed. Each have at
least one full-length ORF sequence characterized and encompass
a minimum of three epidemiologically unrelated isolates. Among
them, genotype 4 (HCV-4) represents one of the most complex
lineages for which 21 subtypes have been designated in addition
to a number of variants that remain unclassiﬁed (Smith et al.,
2014) (http://talk.ictvonline.org/ictv_wikis/w/sg_ﬂavi/56.hcv-clas
siﬁcation.aspx). The HCV genotypes have different geographic
distribution patterns and respond in a different way to antiviral
therapy. Generally, subtypes 1a, 1b, 2a, 2b, and 3a are globally
distributed. In contrast, most other subtypes are restricted to
certain regions (Simmonds et al., 2005). Clinically, genotypes
2 and 3 have shown better responses than genotypes 1 and 4 to
interferon-α and ribavirin standard combination therapy (Feld
and Hoofnagle, 2005; Manns et al., 2006). Although the advent of
direct-acting antivirals (DAAs) may show improved genotype
coverage and response, their approval remain restricted to spe-
ciﬁc genotypes (Delang et al., 2013).
Based on full-length genome sequence data from our previous
study, a total of 17 HCV-4 subtypes (4a–4d, 4f, 4g, 4k–4r, 4v, 4w) are
now conﬁrmed (Li et al., 2009; Smith et al., 2014). Two distinct HCV-
4 variants not assigned to a subtype also have had their genomes
completely sequenced. However, there remain a number of HCV-4
variants that show a considerable degree of genetic diversity from
the other known HCV-4 lineages based on partial genome sequences
(Murphy et al., 2007). In the present study, we determined the full-
length genome sequences for nine such variants further revealing the
extensive diversity and complexity of HCV-4.
Results
Analysis of the full-length genomes
The full-length HCV-4 genome was characterized for nine
isolates represented by QC108, QC127, QC132, QC147, QC215,
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QC253, QC352, QC361, and QC58, each from 16–20 overlapping
fragments (data not shown). These genomes were 9426–9563
nucleotides (nt) in length, starting from the extreme 50-UTR
through to the variable region of the 30-UTR (Table 1). For a more
comprehensive analysis of the nine full-length genome sequences,
a maximum clade credibility (MCC) tree was reconstructed with
the inclusion of 30 reference sequences (Fig. 1). Genotype 4, the
major cluster, is represented by a total of 33 sequences and the
remaining 6 genotypes are each represented by a solitary branch
(genotypes 1-3 and 5-7). In the MCC tree, the genotype 4 cluster
Table 1
Patient information for the nine genotype 4 isolates and the number of nucleotides/amino acids in each genomic region.
ID Sex Originb Viral load (Log IU/ml) Full ORF 50UTR E2 NS5A 30UTR
H77a M US 9646 9036/3011 341 1089/363 1344/448 269
4_QC108 M CD 5.98 9441 9036/3012 340 1089/363 1344/448 65
4_QC127 M CD 5.82 9426 9021/3007 340 1086/362 1332/444 65
4_QC132 M RW 6.04 9430 9024/3008 340 1086/362 1335/445 66
4_QC147 M BI 6.36 9426 9021/3007 341 1086/362 1332/444 64
4_QC215 F EG – 9535 9129/3043 340 1089/363 1437/479 66
4_QC253 F CD 6.70 9437 9036/3012 340 1089/363 1344/448 61
4_QC352 M CF 6.67 9431 9024/3008 340 1089/363 1332/444 67
4_QC361 F AF 7.04 9426 9021/3007 341 1089/363 1329/443 64
4_QC58 M CF 6.53 9563 9039/3013 340 1092/364 1344/448 184
a The H77 genome (Genebank accession no. AF009606) of subtype 1a was included as a standard for comparison. Comparing with the H77 genome, eight protein
encoding regions of the nine genotype 4 isolates showed no differences in their numbers of nucleotide: Core (573 nt), E1 (576 nt), NS2 (651 nt), NS3 (1893 nt), NS4A (162 nt),
NS4B (783 nt), NS5B (1776 nt).
b Country codes ofﬁcially assigned in ISO 3166-1: AF: East Africa; BI: Burundi; CD: Democratic of the Congo; CF: Central African Republic; EG: Egypt; RW: Rwanda; US:
United States.
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Fig. 1. MCC tree estimated using full-length genome sequences of HCV. Reference sequences from the conﬁrmed subtypes of genotypes 1, 2, 3, 4, 5, 6, and 7 are included
(black tips), together with the nine new genomes determined in this study (red tips) and two additional unclassiﬁed variants (blue tips). Each genotype is denoted with a
single digit number on the major branches of the tree while all subtypes of genotype 4 are labeled with single lower case letters above the related branches in proximity to
the right tips. Isolates are named using the following format: genotype or subtype.accession number.isolate name.sampling country. To simplify the tree, only the clade
posterior probability supports of less than 1 are shown in italics, otherwise they are equal to 1 but are not shown. A scale bar at the bottom represents 0.10 units of nucleotide
substitution per site. Country codes: BI: Burundi; CA: Canada; CD: Congo; CF: Central Africa; CM: Cameroon; EG: Egypt; FR: France; GB: United Kingdom; HK: Hong Kong; JP:
Japan, ME, Montenegro; NZ: New Zealand; PT: Portugal; RW: Rwanda; US: the United States.
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was supported with a clade probability of 0.99 and proved more
closely related to genotype 1 than to the other ﬁve genotypes.
Within this cluster, a total of 28 taxonomic lineages could be
differentiated including 18 conﬁrmed subtypes (4a–4d, 4f, 4g,
4k–4t, 4v, and 4w), two unclassiﬁed lineages represented by
P025 and BID-G1253, and eight other unclassiﬁed lineages repre-
sented by the genomes characterized in this study. Among the 18
conﬁrmed subtypes, 4s represented by QC361, was newly assigned
in this study. Analysis of Core-E1 and NS5B genome sequences
revealed that QC361 showed a high degree of genetic similarity to
three other QC-isolates (QC348, QC409, and QC547) thus meeting
current criteria for subtype assignment (see Fig. S1 and Fig. 2).
Fig. 1 shows that the HCV-4 cluster can be divided into three major
subsets. The ﬁrst subset is the most complex, containing 13
assigned subtypes (4a down to 4t) and ﬁve unclassiﬁed variants
represented by QC352, QC215, QC127, QC132, and QC147. Among
the latter ﬁve, QC352 and QC127 each showed a relatively shorter
branch, with QC352 positioned between subtypes 4a and 4c and
QC127 between subtypes 4v and 4q. In contrast, QC215, QC132,
and QC147 each showed a relatively longer branch, with QC215
adjacently grouped with subtype 4s and QC132 and QC147
grouped around subtype 4l. The second subset contained two
assigned subtypes, 4b and 4w, and four unclassiﬁed variants
represented by QC253, QC108, QC58, and P026. Among the latter
four, the three QC-genomes determined in this study grouped
closest to subtype 4b. P026 was initially classiﬁed as subtype 4b
(Koletzki et al., 2009), but has later been recategorized as an
unclassiﬁed variant (Smith et al, 2014). In contrast to the above
two subsets, the third subset contained no isolates from this study.
Phylogenies based on the maximized parsimony method and the
maximum likelihood method were also reconstructed, which
showed topologies consistent to that in Fig. 1. For simplicity, these
phylogenies are not shown in this paper.
Pairwise nucleotide similarities were calculated for the full-length
HCV-4 genome sequences. When the nine genomes determined in
this study were compared to each other, the largest similarity of
86.2% was observed between QC108 and QC253, while the smallest
similarity of 77.5% was seen between QC132 and QC58. When these
nine genomes were compared with the 24 reference HCV-4
sequences, the highest similarity of 86.5% was shown between
QC352 and QC381/4c, while the lowest similarity of 77.3% was seen
between QC58 and ED43/4a. Smith et al. (2014) recently observed
that members of the same subtype almost exclusively displayed
nucleotide differences of o13% while members of different subtypes
virtually displayed differences of 415%. In this study, however, we
did identify nucleotide differences that fell into the 13–15% gap.
When QC127 was compared either to QC262/4q or to BID-G1248, a
nucleotide difference of 14.1% was observed. When QC352 was
compared to QC429/4a and QC381/4c, the nucleotide differences
were 14.1% and 13.5%, respectively. Similarly, comparing QC429/4a to
QC381/4c, QC139/4p to QC155/4t, and QC262/4q to BID-G1248/4v,
nucleotide differences of 14.9%, 14.7%, and 14.0%, respectively, were
observed. Because these intermediate results do not arise from
technical problems or a recent recombination event, they would
reﬂect the actual variation as recently discussed (Li et al., 2015).
Pairwise comparison of four subtype 4s isolates was also performed
in their partial Core-E1 and NS5B regions that showed nucleotide
similarities of 7.6–9.6% and 4.6–7.7%, respectively, conﬁrming mem-
bers of the same subtype.
Analysis of partial sequences
A segment of the NS5B region, corresponding to the nucleo-
tides numbered 8276–8615 in H77 genome has been found to
reliably differentiate HCV genotypes and subtypes (Murphy et al.,
2007). For a better understanding of the genetic variation and
epidemiological distribution patterns relating to the nine isolates
characterized in this study, we also analyzed the above NS5B
sequence from 102 isolates representing each of the 22 assigned
subtypes (counting subtype 4s designated in this study) and all
unassigned variants of HCV-4. This resulted in the second MCC
tree shown in Fig. 2, which differentiated 52 lineages at
the subtype level. Among these lineages, 22 assigned subtypes
4a–4t, 4v, and 4w are well separated (Koletzki et al., 2009;
Simmonds et al., 2005; Smith et al., 2014). Of the nine genomes
we determined in this study, excluding QC361 that we assigned as
a new subtype 4s, the other eight each represent one unassigned
lineage. Each of these unassigned lineages contained no more than
two individual isolates, indicating their low frequencies in the
populations that were sampled (Fig. 2). We are now unable to
assign these eight isolates new subtypes, because they do not
meet the presently recommended criteria. These criteria suggest
that future subtype assignments will be only made for lineages
containing sequence data from three or more isolates and for
which the coding region sequence of at least one must be
complete or nearly complete (Smith et al., 2014).
Except for those characterized in the NS5B region, a number of
HCV-4 isolates characterized only in other genomic regions were
also analyzed. However, none of them grouped with the eight
unclassiﬁed variants we determined in this study (data not
shown). The results suggest that all the unclassiﬁed HCV-4
lineages lack sufﬁcient numbers of closely related isolates for
allowing their assignment to new subtypes.
Similarity plotting
To exclude the possibility of viral recombination, pairwise
nucleotide similarity curves were plotted along HCV genomes.
Upon comparison of the nine genomes from this study with each
other, and with the 49 reference sequences shown in Fig. 1, no
such evidence was detected (data not shown).
Discussion
In this study, the full-length genomes were characterized for
nine HCV-4 isolates. Excluding QC361 assigned to subtype 4s, the
other eight genomes each represent an unclassiﬁed lineage differ-
entiable at the subtype level. This was supported not only by the
analysis of full-length genome sequences but also by the analysis
of partial sequences in both Core-E1 and NS5B regions. In previous
reports, two other unclassiﬁed variants of HCV-4 each represent-
ing a distinct lineage, also had their full-length genomes deter-
mined (Newman et al., 2013; Smith et al., 2014). With the
inclusion of these two variants, there are now a total of 10
unclassiﬁed lineages for which a complete genome sequence is
available further indicating the high genetic complexity of HCV-4.
Analysis of partial NS5B sequences revealed many additional
unclassiﬁed lineages of HCV-4 at the subtype level. Such a ﬁnding
implies that HCV-4 is far more complex than that presently
sampled. However, if these variants are not highly prevalent, their
assignment to a new subtype has a little meaning.
Although sampled in Canada, the nine new genomes were all
from patients that had their origins in Africa (Table 1). Likewise, the
majority of sequences in both Figs. 1 and 2 also showed an African
origin. The ancestral origin of HCV-4 in Africa is supported by studies
from sub-Saharan African countries that showed high HCV seropre-
valences and local epidemics in association with multiple HCV-4
lineages. For example, 11.2% of people screened in rural Gabon were
positive for HCV, among whom 92% were infected with HCV-4
strains (Njouom et al., 2012). In Cameroon, HCV seroprevalence
was 11% in a group of high-HIV risk individuals and 16% of the
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Fig. 2. MCC tree of HCV-4 estimated using 102 partial NS5B sequences corresponding to nucleotide positions 8288–8610 in the referenced H77 genome. Each subtype or
subtype analogy is denoted by a half bracket at the right hand side of the tree. These brackets are vertically aligned and each is labeled with single digit number 4 if it refers
to an unclassiﬁed lineage or is followed by a lower case letter if it refers to an assigned subtype. A purple vertical dash line in the middle of the tree delimits the genetic
distance at which the 22 assigned HCV-4 subtypes are separable from each other and for which an additional 30 unclassiﬁed lineages can be also differentiated. At the root of
the tree, the outlier H77 is indicated. A scale bar at the bottom represents 0.075 units of nucleotide substitution per site. The nine genomes from this study are shown in red
tips whereas those four sequences from the report by Iles et al. (2014) are indicated with blue tips. In addition to country codes indicated in Fig. 1, the other codes are: GA:
Gabon; CY: Cyprus; ZA: South Africa; MA: Malaysia.
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isolates were classiﬁed as HCV-4 (Ndjomou et al., 2003). In another
study from Cameroon on individuals aged 460, about 56% of the
infections were due to HCV-4 strains (Pépin et al., 2010). In a recent
study based on 1999 members of the uniformed services in the
Democratic Republic of Congo, the seroprevalence of HCV was 3%
and all the classiﬁed HCV sequences belonged to genotype 4,
comprising subtypes 4c, 4k, 4h and 4r, as well as a potential new
subtype candidate (Iles et al., 2014). In each of these studies,
however, the seroprevalence of HCV was associated with patient
age and multiple HCV lineages were detected, indicating the indi-
genous and long-term endemic circulation of HCV-4. Diverse HCV-4
isolates are also common in Europe. However, this could have
resulted from the historical roles played by the European explorers
in Africa (Markov et al., 2012) and the fact that many immigrants
from Africa are now residing in Europe. In addition, there has been
rapid growth in the prevalence of HCV subtypes 4a and 4d in Europe
in recent decades, particularly among IDUs (Ciccozzi et al., 2012; de
Bruijne et al., 2009; van Asten et al., 2004). Subtypes 4a and 4d have
also been found in North America among the local population likely
acquired through injection drug use (Murphy et al., 2007).
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Materials and methods
Subjects and specimens
In the Canadian province of Quebec, serum samples from
patients, who were positive for HCV, are generally submitted from
hospital laboratories or private clinics to the Laboratoire de Santé
Publique du Québec for routine HCV genotyping. This resulted in a
large collection of samples that had their partial HCV sequences
determined and classiﬁed into various genotypes and subtypes
(Murphy et al., 2007). Among them, nine samples, QC108, QC127,
QC132, QC147, QC215, QC253, QC352, QC361, and QC58, collected
from 2003–2009 were found to contain unique HCV-4 strains and
were selected for further characterization in this study. Detailed
information about the patients' gender, geographic origin and HCV
viral load are shown in Table 1.
PCR ampliﬁcation and sequencing
Full-length HCV-4 genomes were each determined from a
100 ml serum sample. Brieﬂy, the RNA extraction (Qiagen Viral
RNA extraction kit, Qiagen, Valencia, CA) and the cDNA synthesis
(RevertAid First Strand cDNA Synthesis Kit, Fermentas Life Science,
EU) were performed according to the manufacturer's protocols.
Genomic fragments overlapping the full-length HCV-4 genomes
were ampliﬁed in conventional PCR using degenerate primers as
previously described (Li et al., 2009) or in combination with those
speciﬁc primers designed based on the obtained sequences.
Standard procedures were adopted to avoid potential carryover
contamination (Kwok and Higuchi, 1989). Amplicons were
sequenced as previously described (Li et al., 2009).
Sequence datasets and inspection
The obtained nine full-length genomes were annotated accord-
ing to the standard nucleotide numbering in the H77 genome,
from the extreme 50-end through to the 30-UTR (Kuiken et al.,
2006). To determine the phylogenetic relationship, we retrieved
24 full-length HCV-4 sequences representing subtypes 4a-4d,
4f-4g, 4k-4r, 4t, 4v-4w, the two HCV-4 unassigned variants BID-
G1253 and P026 (Smith et al, 2014) and an additional six
sequences representing each of the other six genotypes for a total
of 39 full-length genome sequences.
To better explore the epidemiology and genetic relationship of
HCV-4 variants related to our new isolates, an additional NS5B
sequence dataset was assembled representing each assigned
subtypes and all unassigned subtype variants of genotype 4
(http://hcv.lanl.gov/content/index). As a result, 102 sequences of
HCV-4 were included, each of which has approximately 323
nucleotides in length, corresponding to nucleotide positions
8288–8610 in the H77 genome.
The two sequence datasets were then aligned using the BioEdit
software (Tippmann, 2004) followed by visual inspection and
manual adjustments. To exclude possible recent viral recombina-
tion events, the RDP3 software (Martin et al., 2010) was run with
settings as previously described (Lu et al., 2007) for the full length
sequence dataset.
Phylogenetic analyses
The BEAST software was used to analyze the two datasets
under the combination of the GTRþ IþГ6 substitution model,
uncorrelated lognormal clock model, and the Bayesian skyline
model to reconstruct the maximum clade credibility (MCC) trees
(Drummond and Rambaut, 2007). For this purpose, we selected a
rate of 1.0 in the panel of “Clock Models”, which would result in
the nodes and branches of the tree being estimated in units of
substitution/sites based on the Markov Chain Monte Carlo (MCMC)
algorithm. Except for that above mentioned, all the other BEAST
procedures were the same as that we have recently described
(Li et al., 2014).
Genbank accession numbers
The nucleotide sequences reported in this study were depos-
ited in Genbank with the following accession numbers: JF735127,
JF735129-JF735132, JF735134-JF735138.
Appendix A. Supporting information
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.virol.2015.03.038.
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